# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Mitochondrial disorders

Mitochondrial genetic disordersMitochondrial diseases
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 239 results.
Survey on Supplement Use in Mitochondrial Disease
Status: Completed
Last Changed: Sep 22, 2016
First Received: Dec 08, 2014
Disease(s): Mitochondrial Disease
Locations: University of South Florida, Tampa, Florida, United States
DNA QUANTIFICATION TECHNIQUE AS A INTERPRETATION TOOL IN MITOCHONDRIAL DISEASES
Status: Unknown status
Last Changed: Jul 24, 2018
First Received: Jul 13, 2017
Disease(s): Mitochondrial Diseases
Intervention(s): samples
Locations: CHU de Nice, Nice, France
An Observational Study of Patients With Primary Mitochondrial Disease (SPIMM-300)
Status: Completed
Last Changed: Apr 11, 2019
First Received: Feb 09, 2017
Disease(s): Primary Mitochondrial Disease
Locations: University of California San Diego, La Jolla, California, United States
Stanford Universtity, Palo Alto, California, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Massachusetts General Hospital, Boston, Massachusetts, United States
Columbia University Medical Center, New York, New York, United States
... and 29 other locations.
A Long-term Extension of Study RP103-MITO-001 (NCT02023866) to Assess Cysteamine Bitartrate Delayed-release Capsules (RP103) in Children With Inherited Mitochondrial Disease
Status: Terminated
Last Changed: May 11, 2018
First Received: Jun 16, 2015
Disease(s): Mitochondrial Diseases
Intervention(s): Cysteamine Bitartrate
Locations: University of California at San Diego (UCSD), San Diego, California, United States
Stanford University School of Medicine, Stanford, California, United States
Akron Children's Hospital, Akron, Ohio, United States
Baylor College of Medicine, Houston, Texas, United States
University of Utah, Salt Lake City, Utah, United States
... and 1 other locations.
The Effect of Arginine and Citrulline Supplementation on Endothelial Dysfunction in Mitochondrial Diseases
Status: Completed
Last Changed: Mar 18, 2020
First Received: Jun 22, 2016
Disease(s): Mitochondrial Diseases
Intervention(s): Arginine, Citrulline
Locations: Tawam Hospital, Al Ain, United Arab Emirates
A First in Human Study to Evaluate the Safety of Infusion of MNV-BM-PLC (Autologous CD34+ Cells Enriched With Placenta Derived Allogeneic Mitochondria) in Patients With Primary Mitochondrial Diseases Associated With Mitochondrial DNA Mutation or Deletion
Status: Not yet recruiting
Last Changed: Sep 15, 2020
First Received: Sep 15, 2020
Disease(s): Primary Mitochondrial Diseases
Intervention(s): Bone Marrow mobilization, Apheresis, MNV-BM-PLC infusion
Locations: Sheba Medical Center - Tel Ashomer, Ramat Gan, Israel
Phase III Trial of Coenzyme Q10 in Mitochondrial Disease
Status: Completed
Last Changed: Sep 11, 2017
First Received: Feb 08, 2007
Disease(s): Mitochondrial Diseases
Intervention(s): CoenzymeQ10, Placebo
Locations: Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Case Western Reserve University, Cleveland, Ohio, United States
Hospital for Sick Children, Toronto, Ontario, Canada
Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity During the COVID19 Pandemic
Status: Recruiting
Last Changed: Sep 30, 2020
First Received: Jun 09, 2020
Disease(s): Mitochondrial Disease
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
RG2133 (2',3',5'-Tri-O-Acetyluridine) in Mitochondrial Disease
Status: Terminated
Last Changed: Aug 05, 2005
First Received: May 08, 2003
Disease(s): Mitochondrial Diseases
Intervention(s): RG2133 (2',3',5'-tri-O-acetyluridine)
A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy
Status: Not yet recruiting
Last Changed: Jun 19, 2020
First Received: May 07, 2020
Disease(s): Mitochondrial Diseases, Drug Resistant Epilepsy
Intervention(s): Vatiquinone, Placebo